Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Amprenavir
Drug ID BADD_D00136
Description Amprenavir is a protease inhibitor used to treat HIV infection.
Indications and Usage For the treatment of HIV-1 infection in combination with other antiretroviral agents.
Marketing Status Discontinued
ATC Code J05AE05
DrugBank ID DB00701
KEGG ID D00894
MeSH ID C095108
PubChem ID 65016
TTD Drug ID D0A0OO
NDC Product Code Not Available
Synonyms amprenavir | tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate | (3S-(3R*(1R*,2S*)))-(3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate | VX 478 | VX-478 | Vertex VX478 | Agenerase
Chemical Information
Molecular Formula C25H35N3O6S
CAS Registry Number 161814-49-9
SMILES CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001--Not Available
Abdominal pain07.01.05.002--
Affective disorder19.04.04.001--Not Available
Alanine aminotransferase increased13.03.01.003--
Amylase increased13.05.01.009--
Angioedema10.01.05.009; 23.04.01.001--Not Available
Aspartate aminotransferase increased13.03.01.006--
Asthenia08.01.01.001--Not Available
Blood creatine phosphokinase increased13.04.01.001--
Blood triglycerides increased13.12.03.001--Not Available
Breast enlargement21.05.04.001--Not Available
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Diabetes mellitus05.06.01.001; 14.06.01.001--Not Available
Diarrhoea07.02.01.001--
Discomfort08.01.08.003--Not Available
Dysgeusia07.14.03.001; 17.02.07.003--
Dyspepsia07.01.02.001--
Erythema multiforme10.01.03.015; 23.03.01.003--
Fatigue08.01.01.002--
Flatulence07.01.04.002--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Headache17.14.01.001--
Hepatitis B09.01.09.003; 11.05.06.002--
Hyperbilirubinaemia01.06.04.003; 09.01.01.003; 14.11.01.010--Not Available
Hypercholesterolaemia14.08.01.001--Not Available
Hyperglycaemia05.06.02.002; 14.06.02.002--
Hyperlactacidaemia14.01.01.006--Not Available
Hypertriglyceridaemia14.08.02.001--
The 1th Page    1 2 3    Next   Last    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene